A field resource for the glioma cerebrospinal fluid proteome: Impacts of resection and location on biomarker discovery

The intracranial glioma CSF proteome serves as a rich and dynamic reservoir of potential biomarkers that can be used to evaluate the effects of resection and other therapies over time. All data within this study, including detailed individual clinical annotations, are shared as a resource for the neuro-oncology community to collectively address these unanswered questions and further understand glioma biology through CSF proteomics.

Authors

Institutions

Publication Details

Journal
Neuro-Oncology
Published
2024-12-27
DOI
https://doi.org/10.1093/neuonc/noae277
Citations
8
Primary Topic
Glioma Diagnosis and Treatment
Type
article
Field-Weighted Citation Impact
3.50

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

A field resource for the glioma cerebrospinal fluid proteome: Impacts of resection and location on biomarker discovery

Fredric B. Meyer, Terry C. Burns, Christopher Graser, Uğur Sener et al.
8 citations
Neuro-Oncology
Glioma Diagnosis and Treatment
3.50
article

A field resource for the glioma cerebrospinal fluid proteome: Impacts of resection and location on biomarker discovery

Fredric B. Meyer, Terry C. Burns, Christopher Graser, Uğur Sener, Jann Nagina Sarkaria, Benjamin Himes, Katherine M. Andersen, Amanda Munoz-Casabella, Arthur E. Warrington, Sani H. Kizilbash, Jian Campian, Cécile Riviere-Cazaux, Ian F. Parney, Keyvan Ghadimi, Jamie J. Van Gompel, Surendra Dasari, Ignacio Jusué-Torres, Lucas P. Carlstrom, Franziska Michor, Elizabeth A. Palmer, Samar Ikram, Matthew D. Hoplin, Noor Malik
article en
8 citations

Abstract

The intracranial glioma CSF proteome serves as a rich and dynamic reservoir of potential biomarkers that can be used to evaluate the effects of resection and other therapies over time. All data within this study, including detailed individual clinical annotations, are shared as a resource for the neuro-oncology community to collectively address these unanswered questions and further understand glioma biology through CSF proteomics.

Neuro-OncologyVol. 27(4)
Broad Institute (US), Albert Einstein College of Medicine (US), Mayo Clinic (US), Harvard University (US), Harvard University Press (US), The Bronx Defenders (US), Columbus Oncology and Hematology Associates (US), Dana-Farber Cancer Institute (US), University of Minnesota Rochester (US), Mayo Clinic in Arizona (US), Mayo Clinic in Florida (US), Harvard Stem Cell Institute (US), Neurological Surgery (US), The Ohio State University (US)
Center for Clinical and Translational Science, Mayo Clinic, Center for Individualized Medicine, Mayo Clinic, National Cancer Institute, National Institute of Neurological Disorders and Stroke
Openalex Percentile: Top 7%
Glioma Diagnosis and Treatment
3.50
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.